Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1650142 | 1.00 | TDP1 (0.60) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL18586001 | 1.00 | TDP1 (0.60) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL5983536 | 0.98 | TDP1 (0.57) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL9793504 | 0.98 | TDP1 (0.57) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL13917736 | 0.97 | PDE4A (0.58) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL13917735 | 0.97 | PDE4A (0.58) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL769787 | 0.97 | PDE4A (0.58) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL2933537 | 0.92 | PDE4A (0.52) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL19327387 | 0.92 | PDE4A (0.52) | TDP1PDE4ALMNAL3MBTL1USP2 | |
| SCHEMBL769397 | 0.92 | PDE4A (0.52) | TDP1PDE4ALMNAL3MBTL1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6060512-A | Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging | TRISTRATA TECHNOLOGY, INC. (US) | 2000-05-09 | — | — | US | claimed |
| US-20180243309-A1 | TOPICAL ANTIVIRAL COMPOSITIONS | TOPICAL REMEDY LLC (US) | 2018-08-30 | — | — | US | disclosed |
| EP-3344265-A1 | TOPICAL ANTIVIRAL COMPOSITIONS | Topical Remedy, LLC (US) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017040844-A1 | TOPICAL ANTIVIRAL COMPOSITIONS | TOPICAL REMEDY, LLC (US) | 2017-03-09 | — | — | WO | disclosed |
| CN-101711165-B | Artificial invaplex | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY, WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2016-02-24 | — | — | CN | disclosed |
| CN-101711165-A | Artificial invaplex | US SEC THE ARMY WALTER REED AR | 2010-05-19 | — | — | CN | disclosed |
| EP-1633405-A4 | DISINFECTION, DESTRUCTION OF NEOPLASTIC GROWTH, AND STERILIZATION BY DIFFERENTIAL ABSORPTION OF ELECTROMAGNETIC ENERGY | ADVANCED LIGHT TECHNOLOGIES LL (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1633405-A2 | DISINFECTION, DESTRUCTION OF NEOPLASTIC GROWTH, AND STERILIZATION BY DIFFERENTIAL ABSORPTION OF ELECTROMAGNETIC ENERGY | Advanced Light Technologies LLC (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2005021049-A2 | DISINFECTION, DESTRUCTION OF NEOPLASTIC GROWTH, AND STERILIZATION BY DIFFERENTIAL ABSORPTION OF ELECTROMAGNETIC ENERGY | ADVANCED LIGHT TECHNOLOGIES LLC (US) | 2005-03-10 | — | — | WO | disclosed |